Azithramycine

Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.

Cross Reference

Introduction

To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Azithramycine?

Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Azithramycine

MeSH term MeSH ID Detail
Pericoronitis D010497 2 associated lipids
Tuberculosis, Urogenital D014401 2 associated lipids
Moraxellaceae Infections D045828 3 associated lipids
Abdominal Abscess D018784 2 associated lipids
Pyloric Stenosis, Hypertrophic D046248 2 associated lipids
Hoarseness D006685 2 associated lipids
Scrub Typhus D012612 3 associated lipids
Tuberculosis, Avian D014379 2 associated lipids
Pneumocystis Infections D016720 1 associated lipids
Frontal Sinusitis D015522 1 associated lipids
Per page 10 20 50 100 | Total 276

PubChem Associated disorders and diseases

What pathways are associated with Azithramycine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Azithramycine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Azithramycine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Azithramycine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Azithramycine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Azithramycine?

Mouse Model

Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).

Knock-out

Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).

Tissue Model

Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Azithramycine

Download all related citations
Per page 10 20 50 100 | Total 4404
Authors Title Published Journal PubMed Link
Lück PC and Steinert M [Pathogenesis, diagnosis and therapy of Legionella infections]. 2006 Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz pmid:16596363
Amory JK et al. Clinical problem-solving. A jaundiced eye. 2006 N. Engl. J. Med. pmid:16598049
Brkljacić N et al. Stevens-Johnson syndrome as an unusual adverse effect of azithromycin. 2006 Acta Dermatovenerol Croat pmid:16603101
Felstead SJ and Daniel R Short-course treatment of sinusitis and other upper respiratory tract infections with azithromycin: a comparison with erythromycin and amoxycillin. European Azithromycin Study Group. 1991 Sep-Oct J. Int. Med. Res. pmid:1660823
Daniel R Simplified treatment of acute lower respiratory tract infection with azithromycin: a comparison with erythromycin and amoxycillin. European Azithromycin Study Group. 1991 Sep-Oct J. Int. Med. Res. pmid:1660824
Fairgrieve WT et al. Concentrations of erythromycin and azithromycin in mature Chinook salmon Oncorhynchus tshawytscha after intraperitoneal injection, and in their progeny. 2006 Dis. Aquat. Org. pmid:16610588
Asbel LE et al. School-based screening for Chlamydia trachomatis and Neisseria gonorrhoeae among Philadelphia public high school students. 2006 Sex Transm Dis pmid:16614587
Sevillano D et al. Azithromycin iv pharmacodynamic parameters predicting Streptococcus pneumoniae killing in epithelial lining fluid versus serum: an in vitro pharmacodynamic simulation. 2006 J. Antimicrob. Chemother. pmid:16617063
Brook I and Hausfeld JN Effect of telithromycin and azithromycin on nasopharyngeal bacterial flora in patients with acute maxillary sinusitis. 2006 Arch. Otolaryngol. Head Neck Surg. pmid:16618915
Barr BS Rhodococcus equi pneumonia in a foal. 2006 Vet. Clin. North Am. Equine Pract. pmid:16627120
Stuhne-Sekalec L et al. Liposomes as carriers of macrolides: preferential association of erythromycin A and azithromycin with liposomes of phosphatidylglycerol containing unsaturated fatty acid(s). 1991 Apr-Jun J Microencapsul pmid:1662717
Wilms EB et al. Pharmacokinetics of azithromycin in plasma, blood, polymorphonuclear neutrophils and sputum during long-term therapy in patients with cystic fibrosis. 2006 Ther Drug Monit pmid:16628134
Wareham DW and Bean DC In-vitro activity of polymyxin B in combination with imipenem, rifampicin and azithromycin versus multidrug resistant strains of Acinetobacter baumannii producing OXA-23 carbapenemases. 2006 Ann. Clin. Microbiol. Antimicrob. pmid:16630352
Daniel R Azithromycin, erythromycin and cloxacillin in the treatment of infections of skin and associated soft tissues. European Azithromycin Study Group. 1991 Nov-Dec J. Int. Med. Res. pmid:1663466
Ball AP Azithromycin: an interim analysis. 1991 Nov-Dec J. Int. Med. Res. pmid:1663467
Miedinger D [Dysuria and urethral discharge after travel abroad]. 2006 Praxis (Bern 1994) pmid:16640179
Nalca Y et al. Quorum-sensing antagonistic activities of azithromycin in Pseudomonas aeruginosa PAO1: a global approach. 2006 Antimicrob. Agents Chemother. pmid:16641435
Asgrimsson V et al. Novel effects of azithromycin on tight junction proteins in human airway epithelia. 2006 Antimicrob. Agents Chemother. pmid:16641453
O'Farrell N et al. Periodic presumptive treatment for cervical infections in service women in 3 border provinces of Laos. 2006 Sex Transm Dis pmid:16645552
Plana MT et al. Toxic catatonia secondary to azithromycin. 2006 J Clin Psychiatry pmid:16649839
Clarithro- and azithromycin--better erythromycins? 1991 Drug Ther Bull pmid:1665125
Amer A and Fischer H Azithromycin does not cure pityriasis rosea. 2006 Pediatrics pmid:16651327
Pedro-Botet L and Yu VL Legionella: macrolides or quinolones? 2006 Clin. Microbiol. Infect. pmid:16669926
Bermudez LE et al. Stimulation with cytokines enhances penetration of azithromycin into human macrophages. 1991 Antimicrob. Agents Chemother. pmid:1667256
Mikamo H et al. [Prevalence and treatment of pharyngeal Chlamydia trachomatis infections]. 2006 Jpn J Antibiot pmid:16673581
Atasoy M et al. A case of early onset confluent and reticulated papillomatosis with an unusual localization. 2006 J. Dermatol. pmid:16674793
Rehg JE Anti-cryptosporidial activity of macrolides in immunosuppressed rats. 1991 Nov-Dec J. Protozool. pmid:1667930
Kimata I et al. Chemotherapeutic effect of azithromycin and lasalocid on Cryptosporidium infection in mice. 1991 Nov-Dec J. Protozool. pmid:1667931
Zhang H et al. Impact of oral azithromycin on recurrence of trachomatous trichiasis in Nepal over 1 year. 2006 Br J Ophthalmol pmid:16687452
Ivetić Tkalcević V et al. Anti-inflammatory activity of azithromycin attenuates the effects of lipopolysaccharide administration in mice. 2006 Eur. J. Pharmacol. pmid:16698012
Giles DK et al. Ultrastructural analysis of chlamydial antigen-containing vesicles everting from the Chlamydia trachomatis inclusion. 2006 Microbes Infect. pmid:16698305
Konstantinopoulos PA et al. Babesiosis masquerading as recurrent immune thrombocytopenic purpura in a splenectomized patient. 2006 Ann. Hematol. pmid:16705453
Moon JE et al. Efficacy of macrolides and telithromycin against leptospirosis in a hamster model. 2006 Antimicrob. Agents Chemother. pmid:16723556
Bogdanovich T et al. Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis. 2006 Antimicrob. Agents Chemother. pmid:16723565
Kosowska-Shick K et al. Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents. 2006 Antimicrob. Agents Chemother. pmid:16723567
Zhanel GG et al. Mutant prevention concentrations of levofloxacin alone and in combination with azithromycin, ceftazidime, colistin (Polymyxin E), meropenem, piperacillin-tazobactam, and tobramycin against Pseudomonas aeruginosa. 2006 Antimicrob. Agents Chemother. pmid:16723591
Petrini B Mycobacterium abscessus: an emerging rapid-growing potential pathogen. 2006 APMIS pmid:16725007
Enders M et al. Antimicrobial resistance of Neisseria gonorrhoeae isolates from the Stuttgart and Heidelberg areas of southern Germany. 2006 Eur. J. Clin. Microbiol. Infect. Dis. pmid:16733613
Hodge S et al. Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages. 2006 Eur. Respir. J. pmid:16737992
Verleden GM et al. Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome. 2006 Am. J. Respir. Crit. Care Med. pmid:16741151
Sultana N et al. Degradation studies of azithromycin and its spectrophotometric determination in pharmaceutical dosage forms. 2006 Pak J Pharm Sci pmid:16751118
Bryant KA et al. Measures to control an outbreak of pertussis in a neonatal intermediate care nursery after exposure to a healthcare worker. 2006 Infect Control Hosp Epidemiol pmid:16755471
Giugliani C et al. Feasibility of azithromycin prophylaxis during a pertussis outbreak among healthcare workers in a university hospital in Paris. 2006 Infect Control Hosp Epidemiol pmid:16755485
Saha D et al. Single-dose azithromycin for the treatment of cholera in adults. 2006 N. Engl. J. Med. pmid:16760445
Guerrant RL Cholera--still teaching hard lessons. 2006 N. Engl. J. Med. pmid:16760452
Dimitrijević A et al. Micronucleus frequency in women with genital Chlamydia Trachomatis infection before and after therapy. 2006 Mutat. Res. pmid:16777475
Esposito S et al. Acute tonsillopharyngitis associated with atypical bacterial infection in children: natural history and impact of macrolide therapy. 2006 Clin. Infect. Dis. pmid:16779748
An N et al. [Severe liver damage caused by intravenous infusion of azithromycin in a case]. 2006 Zhonghua Er Ke Za Zhi pmid:16780660
Alou L et al. A pharmacodynamic approach to antimicrobial activity in serum and epithelial lining fluid against in vivo-selected Streptococcus pneumoniae mutants and association with clinical failure in pneumonia. 2006 J. Antimicrob. Chemother. pmid:16782744
Falcó V et al. [Treatment for Legionnaires' disease. Macrolides or quinolones?]. 2006 Jun-Jul Enferm. Infecc. Microbiol. Clin. pmid:16792936
Liu CL et al. [Current infection of Mycoplasma pneumoniae in adults: clinical analysis of 13 hospitalized patients]. 2006 Zhonghua Yi Xue Za Zhi pmid:16796860
Colakoglu S et al. Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Ankara, Turkey. 2006 Scand. J. Infect. Dis. pmid:16798693
Clement A et al. Long term effects of azithromycin in patients with cystic fibrosis: A double blind, placebo controlled trial. 2006 Thorax pmid:16809416
Chen BM et al. Quantitative determination of azithromycin in human plasma by liquid chromatography-mass spectrometry and its application in a bioequivalence study. 2006 J Pharm Biomed Anal pmid:16822633
Young LS et al. Azithromycin for treatment of Mycobacterium avium-intracellulare complex infection in patients with AIDS. 1991 Lancet pmid:1682544
Argani H et al. Treatment of cyclosporine-induced gingival overgrowth with azithromycin-containing toothpaste. 2006 Exp Clin Transplant pmid:16827637
Thoms KM et al. [Two brothers with brown, reticulate hyperpigmentations. Papillomatosis confluens et reticularis (Gougerot-Carteaud): familial occurrence and response to azithromycin]. 2006 J Dtsch Dermatol Ges pmid:16827916
Bradshaw CS et al. Azithromycin failure in Mycoplasma genitalium urethritis. 2006 Emerging Infect. Dis. pmid:16836839
Russo V et al. Azithromycin-induced QT prolongation in elderly patient. 2006 Acta Biomed pmid:16856707
Yasojima M et al. Occurrence of levofloxacin, clarithromycin and azithromycin in wastewater treatment plant in Japan. 2006 Water Sci. Technol. pmid:16862794
Edvinsson M et al. Chlamydophila pneumoniae in chronic rhinosinusitis. 2006 Acta Otolaryngol. pmid:16864493
Mousavi S et al. Azithromycin in one week quadruple therapy for H pylori eradication in Iran. 2006 World J. Gastroenterol. pmid:16874871
Merriam CV et al. In vitro activity of azithromycin and nine comparator agents against 296 strains of oral anaerobes and 31 strains of Eikenella corrodens. 2006 Int. J. Antimicrob. Agents pmid:16875802
Horner P The case for further treatment studies of uncomplicated genital Chlamydia trachomatis infection. 2006 Sex Transm Infect pmid:16877590
Huang W et al. [Spectrophotometric determination of azithromycin by charge transfer reaction]. 2006 Guang Pu Xue Yu Guang Pu Fen Xi pmid:16883867
Chaudhry SI et al. A rash on the back. Diagnosis: confluent and reticulated papillomatosis (CRP) of Gougerot and Carteaud. 2006 Clin. Exp. Dermatol. pmid:16901326
Cárceles CM et al. Tissue disposition of azithromycin after intravenous and intramuscular administration to rabbits. 2007 Vet. J. pmid:16904354
West SK et al. Intensive insecticide spraying for fly control after mass antibiotic treatment for trachoma in a hyperendemic setting: a randomised trial. 2006 Lancet pmid:16905024
Emerson PM et al. The SAFE strategy for trachoma control: Using operational research for policy, planning and implementation. 2006 Bull. World Health Organ. pmid:16917648
Vladusić I et al. [Long term survival after Rhodococcus equi pneumonia in a patient with human immunodeficiency virus infection in the era of highly active antiretroviral therapy: case report and review]. 2006 Acta Med Croatica pmid:16933840
Bergman M et al. Macrolide and azithromycin use are linked to increased macrolide resistance in Streptococcus pneumoniae. 2006 Antimicrob. Agents Chemother. pmid:16940064
Dolgushin II et al. [Immunological and microbiological aspects of low intensity laser effect on the factors of local immunity of the reproductive tract in women with chlamydia infection]. 2006 Jul-Aug Zh. Mikrobiol. Epidemiol. Immunobiol. pmid:16941885
Rackstraw S et al. Can chlamydial conjunctivitis result from direct ejaculation into the eye? 2006 Int J STD AIDS pmid:16942659
Furuya R et al. In vitro synergistic effects of double combinations of beta-lactams and azithromycin against clinical isolates of Neisseria gonorrhoeae. 2006 J. Infect. Chemother. pmid:16944253
Onodera S et al. Enhancement of antimicrobial activities of cefteram or clavulanic acid/amoxicillin against cefixime-resistant Neisseria gonorrhoeae in the presence of clarithromycin or azithromycin. 2006 J. Infect. Chemother. pmid:16944260
Tungikar SL et al. Primary amebic meningoencephalitis. 2006 J Assoc Physicians India pmid:16944619
Hand WL et al. Increased polymorphonuclear leukocyte respiratory burst function in type 2 diabetes. 2007 Diabetes Res. Clin. Pract. pmid:16959366
Daoud S and Boushi L Azithromycin, ineffective in the treatment of old-world cutaneous leishmaniasis. 2006 Int. J. Dermatol. pmid:16961538
Dean NC et al. Improved clinical outcomes with utilization of a community-acquired pneumonia guideline. 2006 Chest pmid:16963677
Rafiei R and Yaghoobi R Azithromycin versus tetracycline in the treatment of acne vulgaris. 2006 J Dermatolog Treat pmid:16971315
Atasoy M and AliaÄŸaoÄŸlu C Is confluent and reticulated papillomatosis without papillomatosis early or late stage of confluent and reticulated papillomatosis? 2006 J. Cutan. Pathol. pmid:16972956
Low N Chlamydia (uncomplicated, genital). 2006 Clin Evid pmid:16973080
Wagner BK et al. Complications of a cat bite. 2006 Sep-Oct J Am Podiatr Med Assoc pmid:16988179
Paul SR et al. Polymorphous hemangioendothelioma in a child with acquired immunodeficiency syndrome (AIDS). 2008 Pediatr Blood Cancer pmid:16991137
Atik B et al. Impact of annual targeted treatment on infectious trachoma and susceptibility to reinfection. 2006 JAMA pmid:17003397
Cochereau I et al. Efficacy and safety of short duration azithromycin eye drops versus azithromycin single oral dose for the treatment of trachoma in children: a randomised, controlled, double-masked clinical trial. 2007 Br J Ophthalmol pmid:17005549
Caronzolo D et al. Effect of PEX, a noncatalytic metalloproteinase fragment with integrin-binding activity, on experimental Chlamydophila pneumoniae infection. 2006 Antimicrob. Agents Chemother. pmid:17005805
Fa N et al. Effect of the antibiotic azithromycin on thermotropic behavior of DOPC or DPPC bilayers. 2006 Chem. Phys. Lipids pmid:17007828
Bukvić Krajacić M et al. Azithromycin-sulfonamide conjugates as inhibitors of resistant Streptococcus pyogenes strains. 2007 Eur J Med Chem pmid:17011079
Blau H et al. Moxifloxacin but not ciprofloxacin or azithromycin selectively inhibits IL-8, IL-6, ERK1/2, JNK, and NF-kappaB activation in a cystic fibrosis epithelial cell line. 2007 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:17012372
Halling SM and Jensen AE Intrinsic and selected resistance to antibiotics binding the ribosome: analyses of Brucella 23S rrn, L4, L22, EF-Tu1, EF-Tu2, efflux and phylogenetic implications. 2006 BMC Microbiol. pmid:17014718
Weinstein O et al. Bilateral acute anterior uveitis as a presenting symptom of Mycoplasma pneumoniae infection. 2006 Can. J. Ophthalmol. pmid:17016530
Bonacorsi S et al. Treatment failure of nosocomial pertussis infection in a very-low-birth-weight neonate. 2006 J. Clin. Microbiol. pmid:17021121
De Vecchi E et al. In vitro induction of resistance by tissue concentrations of azithromycin, clarithromycin, cefixime and amoxicillin/clavulanate in clinical isolates of Streptococcus pyogenes. 2006 J Chemother pmid:17024793
Tonkić M et al. Primary resistance and antibiotic minimum inhibitory concentrations for Helicobacter pylori strains, in Split, Croatia. 2006 J Chemother pmid:17024803
Santino I et al. In vitro susceptibility of isolates of Borrelia burgdorferi s.l. to antimicrobial agents. 2006 Jul-Sep Int J Immunopathol Pharmacol pmid:17026839
El-Rabbat N et al. A validated spectrofluorometric assay for the determination of certain macrolide antibiotics in pharmaceutical formulations and spiked biological fluids. 2006 Sep-Oct J AOAC Int pmid:17042176
Kosowska-Shick K et al. Activity of DX-619 compared to other agents against viridans group streptococci, Streptococcus bovis, and Cardiobacterium hominis. 2006 Antimicrob. Agents Chemother. pmid:17043120
Cigana C et al. Anti-inflammatory effects of azithromycin in cystic fibrosis airway epithelial cells. 2006 Biochem. Biophys. Res. Commun. pmid:17045242
Venner M et al. Evaluation of tulathromycin in the treatment of pulmonary abscesses in foals. 2007 Vet. J. pmid:17045497